Laparoscopic ventral mesh rectopexy in the management of solitary rectal ulcer syndrome: a cause for optimism?

Abstract

LVMR appears to provide a sustained improvement in QoL, VAS and patient satisfaction in patients with SRUS. Morbidity, recurrence and safety profiles are low.

A Multicenter Collaboration to Assess the Safety of Laparoscopic Ventral Rectopexy

“…the data interpreted within this study, therefore, include patients who have been reported previously by the individual centers. [3][4][5][8][9][10][11][12][13][14][15][16][17] the indication for patients undergoing lVR was at the discretion of individual center practice. however, 4 of the 5 centers included within this study were involved in the creation of a published consensus for lVR with standardized indications for surgery, 18 and, as such, practice was consistent among all of the centers.…”

STARR surgery in treatment of SRUS: an observational study on clinical outcomes

“…29 Similarly studies conducted by Bardek-Amoudi et al and Evan C et al concluded that STARR is more effective in patients with persistent obstructed defecation. 30,31 No recurrence at the end of 4 years was observed in present study while no recurrence at the end of 2 years with minimal complications were reported in study conducted by Palalo B et al 20 The treatment of solitary rectal ulcer syndrome (SRUS) is notoriously difficult because of its chronicity ,complex etiology, clinical presentation and complications. STARR appears to provide a significantly sustained improvement in ODS score and symptomatic relief with minimal, easily manageable complications and none or low recurrence.…”

Laparoscopic ventral rectopexy is effective for solitary rectal ulcer syndrome when associated with rectal prolapse

“…This approach is likely to have contributed to the good function experienced by the patients and is consistent with the results of Badrek‐Amoudi et al . using the same surgical approach. We believe that the correction of any persistent posterior compartment prolapse after LVR in patients whose SRUS remains unhealed is necessary to treat continuing obstructive defaecation.…”